Courtney O'Konek
Vice President of Corporate CommunicationsMs. Courtney O'Konek is Vice President of Corporate Communications of Olema Oncology, Inc. (formerly known as Olema Pharmaceuticals, Inc.) from September 2024 and brings with her more than 20 years of experience within the biotech and entertainment industries. Prior to joining Olema, Ms. O’Konek served as Executive Director of Corporate Communications at ImmunoGen (acquired by AbbVie) where she led activities across the communications spectrum as the organization transformed into a fully integrated oncology company with the launch of ELAHERE™, the first antibody-drug conjugate approved for certain patients with folate receptor alpha positive platinum-resistant ovarian cancer. Before joining ImmunoGen, Ms. O’Konek served in a multifaceted role at Stallergenes Greer, where she led communications for the Company’s Americas business while also supporting global corporate communications. She began her career in biotech at Shire, where she held a series of increasingly responsible internal communications, community relations, corporate responsibility and corporate brand-focused roles. Early in her career, Ms. O’Konek spent nearly a decade programing market-leading radio stations in Massachusetts and Virginia. She holds a BA in Communications from Virginia Tech.
Positions
- Company NameOlema Oncology, Inc.Stock CodeOLMAPositionVice President of Corporate CommunicationsColleagues
- SPSean P. BohenPresident, CEO & Director
- ITIan T. ClarkIndependent Chairperson of the Board
- SMShawnte M. MitchellChief Legal Officer & Corporate Secretary
- JOJason O’ByrneCFO, Principal Financial Officer & Accounting Officer
- DCDavid C. MylesChief Scientific Officer
- FPFrank P. McCormickChairman of Scientific Advisory Board
- CMCynthia Marie ButittaIndependent Director
- SGScott GarlandIndependent Director
